
Opinion|Videos|January 31, 2025
Faricimab Molecular Design and Role of Ang-2
Panelists discuss how faricimab’s bispecific antibody design uniquely targets both VEGF-A and Ang-2 pathways, addressing the complementary role of Ang-2 in vascular destabilization and inflammation in retinal diseases.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What is the unique nature of the faricimab molecule, and what is the clinical rationale for targeting Ang-2 in treating retinal diseases?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
Retina World Congress 2026: Identifying real-world durability gaps in wet AMD treatment
2
Retina World Congress 2026: Diagnosing macular telangiectasia in a field of mimickers
3
Retina World Congress 2026: The case for earlier surgical intervention in diabetic macular edema
4
Retina World Congress 2026: Rethinking macular hole surgery without gas tamponade
5






















